Acadia Pharmaceuticals | ACAD - Stock


Acadia Pharmaceuticals reported $31.57M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
ALKERMES USD 336.7M 140.08M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
J&J USD 14.58B 392M Mar/2026
Moderna USD 146M 7M Mar/2026
Neurocrine Biosciences USD 64.5M 4.5M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Sarepta Therapeutics USD 1B 86.37M Mar/2026
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026